医学
哮喘
生物药物
重症监护医学
疾病
生活质量(医疗保健)
儿科
免疫学
内科学
护理部
作者
Cristiana Indolfi,Angela Klain,Chiara Lucia Bencivenga,Elisabetta D'Addio,Giulio Dinardo,Alberto Decimo,Michele Miraglia del Giudice
出处
期刊:Current Pediatric Reviews
[Bentham Science]
日期:2023-09-13
卷期号:20 (3): 265-270
被引量:1
标识
DOI:10.2174/1573396320666230912103115
摘要
Abstract: The introduction of biological drugs for the treatment of severe allergic asthma in chil- dren, almost twenty years ago, had a substantial impact on both the pathology's clinical course and the quality of life of the patients who receive treatment. Over the years, several molecules have been developed that inhibit molecular targets involved in the pathogenesis of the asthmatic disease. Biological drugs demonstrate a significant improvement in several key clinical parameters in patients with severe asthma. In this review, we provide a concise summary of the evidence on biological therapy for children and adolescents with severe asthma.
科研通智能强力驱动
Strongly Powered by AbleSci AI